This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Rift Valley Fever Virus Glycoprotein C Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for rift valley fever virus glycoprotein C. It is affinity purified by protein A. It can be applied to SPR, WB, ELISA and FC assays of rift valley fever virus envelopment polyprotein.
Specifications
Target Information
The rift valley fever virus (RVFV) glycoprotein C, also known as Gn, is a key component of the virus's envelope and plays a central role in the infection process. As one of the two major surface glycoproteins of RVFV, glycoprotein C is involved in receptor binding and fusion with the host cell membrane, enabling the virus to enter and initiate infection. Glycoprotein C is a prime target for vaccine development and antiviral therapies due to its critical role in the virus's lifecycle. It is immunogenic, meaning it can elicit a strong immune response, making it a candidate for the design of subunit vaccines. Additionally, understanding the structure and function of glycoprotein C can aid in the development of monoclonal antibodies or small molecules that can inhibit its activity, thereby preventing viral entry into host cells.
Shipping and Storage
This product is shipped at ambient temperature. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Phoenix, Inaia, et al. "N-glycans on the Rift Valley fever virus envelope glycoproteins Gn and Gc redundantly support viral infection via DC-SIGN." Viruses 8.5 (2016): 149.